Orbimed Advisors Llc

Director

Orbimed Advisors Llc (Director) filed 18 Form 4 reports as a reporting entity in the trailing twelve months (10 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 8 priced purchase filings, the average 21-session return was +11.7% from execution and +14.6% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+11.7%

avg across 8 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+14.6%

same 8 filings, from disclosure

Filings, ttm

10 buys · 8 sells · 1 late

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$242.6M

shares × price, as filed

Last traded

Nov 5

Filed Nov 5

Median ADV $26.9M across their filed names

Impact on $10,000 · 12M

$17,583 (+75.8%)

S&P 500 $10,907 (+9.1%) · 66.8 pts ahead

Orbimed Advisors Llc S&P 500

Derived: compounded across filings from disclosure dates · past 12 months

Open performance→

Volume by month

Buys $153.5M Sells $113.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 16 filings Not on file 2 filings

Sector per market data · by filing · past 12 months

Most traded names

SION

Sionna Therapeutics, Inc. SION · 0 buys · 6 sells 6 filings ELVN

Enliven Therapeutics, Inc. ELVN · 0 buys · 2 sells 2 filings ETRA

Electra Therapeutics, Inc. ETRA · 2 buys · 0 sells 2 filings ACET ACET 1 buy · 0 sells 1 filing ADRX

ADARx Pharmaceuticals, Inc. ADRX · 1 buy · 0 sells 1 filing

Recent filings

SIONSALE Sionna Therapeutics, Inc. View filing → $5.3M
115,844 sh × $45.50
Exec Jun 30
Filed Jul 2 · 4:42 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $38.9M
858,646 sh across 3 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $12.7M
281,408 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET QTTBPURCHASE Q32 Bio Inc. View filing → $15.0M
1,875,000 sh across 2 lots
Exec May 28
Filed Jun 1 · 9:13 PM ET SIONSALE Sionna Therapeutics, Inc. View filing → $13.4M
292,952 sh across 3 lots
Exec May 7
Filed May 11 · 5:30 PM ET PRLDPURCHASE Prelude Therapeutics Inc View filing → $12.5M
2,815,315 sh across 2 lots
Exec Apr 21
Filed Apr 23 · 6:48 PM ET SIONSALE Sionna Therapeutics, Inc. View filing → $2.5M
55,345 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET TRAWPURCHASE Traws Pharma, Inc. View filing → $998K
597,729 sh × $1.67
Exec Apr 16
Filed Apr 28 · 9:41 PM ET † More filings →